S-38844
/ Servier, Amgen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 22, 2021
Transient heart rate reduction improves acute decompensated heart failure-induced left ventricular and coronary dysfunction.
(PubMed, ESC Heart Fail)
- "In a model mimicking human ADHF, early, but not delayed, transient HRR induced by the I current inhibitor S38844 opposes acute decompensation by preventing the decompensated-related aggravation of cardiovascular dysfunction as well as the development of pulmonary congestion, and these protective effects persist beyond the transient treatment. Whether early transient HRR induced by I current inhibitors or other bradycardic agents, i.e. beta-blockers, exerts beneficial effects in human ADHF warrants further investigation."
Journal • Cardiovascular • Congestive Heart Failure • Heart Failure • MRI
1 to 1
Of
1
Go to page
1